Technologies related to NIDCR

Custom text
Rescue of AAV Production by shRNA Co-transfection
Ref: TAB-3421 | Updated: 06/04/2021
Rescue Of AAV Production By ShRNA Cotransfection
Ref: E-072-2020-0 | Updated: 06/04/2021
Monoclonal Antibodies that Neutralize B. anthracis Protective Antigen (PA), Lethal Factor (LF) and Edema Factor (EF)
Ref: TAB-1580 | Updated: 06/04/2021
Monoclonal Antibodies Against Bacillus Anthracis Antigens
Ref: TAB-3404 | Updated: 06/04/2021
Chimpaneze Monoclonal Antibodies That Neutralize Lethal And Edema Factors Of Anthrax Toxin
Ref: E-123-2007-0 | Updated: 06/08/2021
Potential New Drugs for Treating or Preventing Pruritus
Ref: TAB-3266 | Updated: 06/04/2021
Blockage Of NPR1 Receptor For Treatment Of Itch
Ref: E-485-2013-1 | Updated: 06/08/2021
Blockage Of NPR1 Receptor For Treatment Of Itch
Ref: E-485-2013-2 | Updated: 06/08/2021
Generation Of Stable Hyaline Cartilage In Vivo By Transplantation Of Human Bone Marrow Stromal Cells With Fibrin Microbeads
Ref: E-152-2017-0 | Updated: 06/08/2021
Regenerative Therapy for Cartilage Damage
Ref: TAB-3242 | Updated: 06/04/2021
Human and Veterinary Cancer Therapeutic Agent Utilizing Anthrax Toxin-Based Technology
Ref: TAB-3166 | Updated: 06/04/2021
An Improved Anthrax Toxin (IC2-PA) Has Strong Efficacy Against All Solid Tumor Types
Ref: E-256-2015-0 | Updated: 06/08/2021
Tumor Targeting Toxin Variants Having Specificity For The Tumor Vasculature Marker CMG2
Ref: E-256-2015-1 | Updated: 06/08/2021
Tumor Targeting Toxin Variants Having Specificity For The Tumor Vasculature Marker CMG2
Ref: E-256-2015-2 | Updated: 06/08/2021
Engineered Anthrax Toxin Variants that Target Cancer
Ref: TAB-2576 | Updated: 06/04/2021
Human and Veterinary Cancer Therapeutic Agent Utilizing Anthrax Toxin-Based Technology
Ref: TAB-3143 | Updated: 06/04/2021
Multimeric Protein Toxins to Target Cells Having Multiple Identifying Characteristics
Ref: TAB-996 | Updated: 06/04/2021
Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metallo...
Ref: E-293-1999-0 | Updated: 06/08/2021
Exploiting The Multimeric Nature Of Certain Protein Toxins To Target Cells Having More Than One Identifying Characteristic
Ref: E-059-2004-0 | Updated: 06/08/2021
Methods Of Using Neodymium Magnet For Rapid Diagnosis Of Infectious And Autoimmune Diseases
Ref: E-190-2015-0 | Updated: 06/08/2021
A Novel Rapid Point-of Care Diagnostic Method for Infectious and Autoimmune Diseases
Ref: TAB-2976 | Updated: 06/04/2021
Rabbit Antisera to Various Matrix, Matricellular, and Other Secreted Proteins
Ref: TAB-2966 | Updated: 06/04/2021
mNFHcre Transgenic Mice
Ref: TAB-2967 | Updated: 06/04/2021
Rabbit Polyclonal Antisera To Human And Various Animal Matrix, Matricellular And Other Secreted Proteins
Ref: E-135-2008-0 | Updated: 06/08/2021
MNFHcre Transgenic Mice
Ref: E-293-2009-0 | Updated: 06/08/2021
WNT1-Induced Secreted Protein-1 Knockout Mouse Model
Ref: TAB-2955 | Updated: 06/04/2021
Use Of A Specific AVPR1B Agonist To Stimulate (or Antagonists To Inhibit) Erythropoiesis In Humans In Case Of Anaemia Or Polycythemia
Ref: E-619-2013-0 | Updated: 06/08/2021
Genetically Engineered AAV5 Vectors For Enhanced Transduction And Reduced Antibody Neutralization
Ref: E-097-2015-0 | Updated: 06/08/2021
Generation And Characterization Of A Novel AAV Useful For Gene Therapy
Ref: E-175-2015-0 | Updated: 06/08/2021
Generation Of WISP1 Deficient Mice For The Study Of Osteogenesis
Ref: E-234-2015-0 | Updated: 06/08/2021
Novel Treatment for Anemia and Polycythemia: AVPR1B Molecules Modulating Erythropoiesis
Ref: TAB-2952 | Updated: 06/04/2021
Modified AAV5 Vectors for Enhanced Transduction and Reduced Antibody Neutralization
Ref: TAB-2953 | Updated: 06/04/2021
A Novel Adeno-Associated Virus for Gene Therapy
Ref: TAB-2954 | Updated: 06/04/2021
Role of Novel Hepatitis Delta Virus Variant in Sjogren’s Syndrome
Ref: TAB-2805 | Updated: 06/04/2021
Hepatitis Delta Virus Detected In Sjogren's Syndrome Salivary Glands
Ref: E-736-2013-0 | Updated: 06/08/2021
Methods of Treating or Preventing Pruritis (Itch)
Ref: TAB-2716 | Updated: 06/04/2021
Nppb Is A Transmitter Of Itch Sensation
Ref: E-485-2013-0 | Updated: 06/08/2021
Treatment Of Autoimmune Xerostomia By AAV2 Mediated Gene Transfer Of Aquaporin 1 To Salivary Gland Epithelia
Ref: E-139-2011-1 | Updated: 06/08/2021
Development of Immune System Tolerance for the Treatment of Autoimmune Disease
Ref: TAB-2657 | Updated: 06/04/2021
Apototic Cell-mediated Induction Of Alloantigen-specific Regulatory T Cells For Prevention Of Transplant Rejection
Ref: E-186-2009-0 | Updated: 06/08/2021
MTOR Inhibition Prevents Epithelial Stem Cell Senescence And Protects From Radiation-induced Mucositis
Ref: E-257-2012-0 | Updated: 06/08/2021
mTOR Inhibition for the Prevention of Epithelial Stem Cell Loss and Mucositis
Ref: TAB-2543 | Updated: 06/04/2021
Diagnostic Test and Therapeutic Target for Sjogren's Syndrome
Ref: TAB-2504 | Updated: 06/04/2021
Diagnosis And Treatment Of Sjogren's Syndrome By Detection And Alteration Of BMP6 Levels Of Expression Locally In The Salivary Gland
Ref: E-232-2011-0 | Updated: 06/08/2021
Diagnosis And Treatment Of Sjogren's Syndrome By Detection And Alteration Of BMP6 Levels Of Expression Locally In The Salivary Gland
Ref: E-232-2011-1 | Updated: 06/08/2021
Adeno-Associated Virus Gene Therapy for Diabetes and Obesity
Ref: TAB-2499 | Updated: 06/04/2021
Treatment Of Diabetes By Expression Of A Novel NGF/exendin-4 Fusion Protein From The Salivary Gland Epithelia
Ref: E-142-2011-0 | Updated: 06/08/2021
AAV Mediated CTLA-4 Gene Transfer to Treat Sjogren's Syndrome
Ref: TAB-2339 | Updated: 06/04/2021
Prevention Of Xerostomia In A Murine Model Of Sjogren's Syndrome By Local Delivery Of Adeno-Associated Virus Mediated Cytotoxic T-lymphocyte Antigen 4-Immunoglobulin G Fusion Protein
Ref: E-087-2011-0 | Updated: 06/08/2021
Diagnostic Assays and Methods of Use for Detection of Filarial Infection
Ref: TAB-2321 | Updated: 06/04/2021
Platform Technology Using Ubiquitin to Improve the Delivery and Efficacy of Cytosolic Targeted Toxins
Ref: TAB-2323 | Updated: 06/04/2021
Wuchereria Bancrofti Specific Molecule For The Immunodiagnosis Of Bancrofitan Filariasis And For Surveillance Following Successful Control Programs
Ref: E-281-2010-0 | Updated: 06/08/2021
Identification of EGFR as A Receptor for AAV6 Transduction
Ref: TAB-2238 | Updated: 06/04/2021
Identification Of EGFR As A Receptor For AAV6 Transduction
Ref: E-194-2010-0 | Updated: 06/08/2021
Simple, Quantitative Sensitive High-throughput Antibody Detection for Lyme Disease
Ref: TAB-2113 | Updated: 06/04/2021
Simple, Quantitative, And Highly Sensitive Antibody Detection For Lyme Disease
Ref: E-036-2010-1 | Updated: 06/08/2021
Diagnostic Biomarker of Metastasis for Improved Clinical Management of Head and Neck Cancer
Ref: TAB-2072 | Updated: 06/04/2021
Identification Of DSG3 As A Biomarker For The Detection Of Occult Metastasis In Sentinel Lymph Nodes
Ref: E-300-2008-0 | Updated: 06/08/2021
Biomarkers for Sjogren's Syndrome
Ref: TAB-2009 | Updated: 06/04/2021
Differentially Expressed MicroRNAs From Minor Salivary Glands
Ref: E-018-2009-1 | Updated: 06/04/2021
Differentially Expressed MicroRNAs From Minor Salivary Glands
Ref: E-018-2009-0 | Updated: 06/08/2021
Serological Screening For HHV-8 Infection Using Antigen Mixtures
Ref: E-063-2009-0 | Updated: 06/08/2021
Antigen Mixtures for Serological Detection of HHV-8 Infection
Ref: TAB-2003 | Updated: 06/04/2021
Prevention of Head and Neck Cancer Using Rapamycin and Its Analogs
Ref: TAB-1895 | Updated: 06/04/2021
Use Of Rapamycin And MTOR-inhibitors As A Chemopreventive Strategy For Head And Neck Squamous Cell Carcinoma
Ref: E-302-2008-0 | Updated: 06/08/2021
Scalable Purification of AAV2, AAV4 or AAV5 Using Ion-Exchange Chromatography
Ref: TAB-1839 | Updated: 06/04/2021
SCALABLE PURIFICATION OF AAV2, AAV4 OR AAV5 USING ION-EXCHANGE CHROMATOGRAPHY.
Ref: E-308-2001-0 | Updated: 06/08/2021
Recombinant Modified Bacillus anthracis Protective Antigen for Use in Vaccines
Ref: TAB-1707 | Updated: 06/04/2021
Creation of a Stable Recombinant Protective Antigen (rPA) Molecule By Deletions of the Chymotrypsin-Sensitive Loop and the Furin-Cleavage...
Ref: E-268-2002-0 | Updated: 06/04/2021
Tendon Stem Cells
Ref: TAB-1764 | Updated: 06/04/2021
Identification, Preparation And Utilization Of Tendon Stem/projenitor Cells And The Use Of Small Leucine-rich Proteolgycans To Control Their Fate
Ref: E-233-2007-0 | Updated: 06/08/2021
Micropatterning of Extracellular Matrix Proteins Using Microphoto-ablation Of Poly vinyl Alcohol (PVA) Monolayers
Ref: TAB-1697 | Updated: 06/04/2021
Micropatterning Of Extracellular Matrix Proteins Using Microphoto-ablation Of Poly(vinyl Alcohol) (PVA) Monolayers
Ref: E-001-2008-0 | Updated: 06/04/2021
Cloning and Characterization of an Avian Adeno-Associated Virus and Uses Thereof
Ref: TAB-874 | Updated: 06/04/2021
Cloning And Characterization Of An Avian Adeno-Associated Virus And Uses Thereof
Ref: E-105-2003-0 | Updated: 06/04/2021
Transcytosis of Adeno-Associated Viruses
Ref: TAB-995 | Updated: 06/04/2021
Transcytosis Of Adeno-associated Viruses
Ref: E-298-2004-0 | Updated: 06/04/2021
Adult Human Dental Pulp Stem Cells in vitro and in vivo
Ref: TAB-196 | Updated: 06/04/2021
Postnatal Stem Cells and Uses Thereof
Ref: TAB-736 | Updated: 06/04/2021
Multipotent Postnatal Stem Cells From Human Periodontal Ligament and Uses Thereof
Ref: TAB-885 | Updated: 06/04/2021
Adult Human Dental Pulp Stem Cells In Vitro and In Vivo
Ref: E-233-2000-0 | Updated: 06/08/2021
Isolation Of Multipotent Post-Natal Stem Cells From Exfoliated Human Primary (Baby) Teeth
Ref: E-018-2003-0 | Updated: 06/08/2021
Multipotent Postnatal Stem Cells From Human Periodontal Ligament
Ref: E-033-2004-0 | Updated: 06/08/2021
A Composition And Method For Inhibting Angiogenesis And Cell Proliferation
Ref: E-320-2001-0 | Updated: 06/04/2021
Compositions and Methods for Inhibiting Vascular Channels and Methods of Inhibiting Proliferation
Ref: TAB-721 | Updated: 06/04/2021
Activation of Recombinant Diphtheria Toxin Fusion Proteins by Specific Proteases Highly Expressed on the Surface of Tumor Cells
Ref: TAB-875 | Updated: 06/04/2021
Activation of Recombinant Diphtheria Toxin Fusion Proteins By Specific Proteases Highly Expressed on the Surface of Tumor Cells
Ref: E-331-2002-0 | Updated: 06/04/2021
Hybrid Adeno-Retroviral Vector for the Transformation of Cells (E-312-2000)
Ref: TAB-419 | Updated: 06/04/2021
Hybrid Adenoviral Vector
Ref: E-312-2000-0 | Updated: 06/04/2021
Hybrid Adeno-Retroviral Vector for the Transformation of Cells (E-258-1998)
Ref: TAB-901 | Updated: 06/04/2021
Hybrid Adeno-Retroviral Vector For the Transformation of Cells
Ref: E-258-1998-0 | Updated: 06/04/2021
Pain Control by the Selective Local Ablation of Nociceptive Neurons
Ref: TAB-832 | Updated: 06/04/2021
Generation of double knockout mice for biglycan and fibromodulin
Ref: E-081-2002-0 | Updated: 06/04/2021
Molecular Neurosurgery for Pain Control.
Ref: E-109-2000-0 | Updated: 06/04/2021
A Mouse Model for Human Osteoarthritis
Ref: TAB-684 | Updated: 06/04/2021
Imaging of Extracellular Proteases in Cells Using Mutant Anthrax Toxin Protective Antigens
Ref: TAB-529 | Updated: 06/04/2021
Imaging The Activity of Extracellular Proteases In Cells Using Mutant Anthax Toxin Protective Antigens That Are Cleaved By Specific...
Ref: E-295-2001-0 | Updated: 06/04/2021
Virally Mediated Gene Therapy For The Control Of Chronic Or Persistent Pain
Ref: TAB-372 | Updated: 06/04/2021
Methods of Treating Chronic Pain
Ref: E-044-1998-0 | Updated: 06/08/2021
Thymosin alpha 1 Promotes Tissue Repair, Angiogenesis and Cell Migration
Ref: TAB-31 | Updated: 06/04/2021

Pages

Subscribe to Technologies related to NIDCR